OCS Stock Price Chart
OCS Financial
Oculis Holding AG
$13.8
-2.26%
$-0.31
At close: Jul 06, 16:00:00 GMT-4
$13.9
0.72%
$0.09
Post-market: Jul 06, 17:25:03 GMT-4
Back
Oculis Holding AG (OCS) Financial
Key Stats
Prev.Close
$14.12
Open
$14
Day's Range
$13.53 - $14.27
52 week range
$10.52 - $34.47
Volume
377.7K
Avg.Volume
557.1K
Dividend yield
--
EPS (TTM)
-1.72
Market Cap
$862.3M
What is OCS?
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The company is headquartered in Zug, Zug and currently employs 49 full-time employees. The company went IPO on 2023-03-03. The firm is focused on the development of eye disease treatment for ophthalmology. The company includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The firm have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
